ART method in prostate cancer screening
AUTHORS : Atyushev G.P. | Skvarnik V. V.
RELEVANT UNIVERSITIES : Pacific State Medical University Medical Center
“DV-Diagnostic”, Vladivostok, Russia
Screening for prostate cancer, which can reduce mortality in men, also has negative consequences. The solution to
the problem is seen by the need to use other options for screening programs (Lopatkin N.A.).
YEAR : 2017
Introduction Prostate cancer (PC) in many countries, including Russia, is one of the most common malignant diseases. According to the research institute them. P.A. Herzen, in 2012 prostate cancer ranks second (12.1%), behind broncho-pulmonary pathology (18.7%). The increase in the incidence of prostate cancer in the Russian Federation makes it possible to predict a doubling of the number of its cases by 2030. In terms of mortality in men from malignant diseases, prostate cancer ranks third (7.1%), behind oncology of the trachea (26.8%), stomach (12.0%) ). Today prostate cancer is considered one of the socially significant
health problems in Russia.
Malignant neoplasm of the prostate (PC) is an extremely controversial disease. This tumor, when the clinic is more
often absent with an elevated level of prostate specific antigen (PSA), is detected by the results of organ biopsy.